GeneDx Holdings Corp. (WGS)
GeneDx Holdings Corp. operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Stamford, CT, US. The stock last traded at $88.40, down 0.09% on the session, giving a market capitalisation of $2.64B. On trailing twelve-month figures it carries a trailing P/E of -24.29, a net margin of -23.4%. Its beta of 2.01 implies it has historically moved more than the broad market.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
GeneDx Holdings Corp. is most often compared with the following Healthcare names: